Manufacturers Life Insurance Company, The Vaxcyte, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 157,024 shares of PCVX stock, worth $13.3 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
157,024
Previous 131,749
19.18%
Holding current value
$13.3 Million
Previous $9.95 Million
80.21%
% of portfolio
0.02%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding PCVX
# of Institutions
357Shares Held
123MCall Options Held
772KPut Options Held
430K-
Vanguard Group Inc Valley Forge, PA11.4MShares$970 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.9MShares$927 Million0.67% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$843 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$737 Million13.83% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.9MShares$416 Million0.12% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $5.03B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...